Kavar Capital Partners Group’s Boston Scientific BSX Stock Holding History

Kavar Capital Partners Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$9K	–	173
2019 Q2	$9K	Buy	+200	New	+$7.69K	﹤0.01%	367
2018 Q3	–	Sell	-200	Closed	-$7K	–	131
2018 Q2	$7K	Hold	200	–	–	﹤0.01%	342
2018 Q1	$5K	Buy	+200	New	+$5.44K	﹤0.01%	369
2016 Q1	–	Sell	-200	Closed	-$3K	–	129
2015 Q4	$3K	Hold	200	–	–	﹤0.01%	325
2015 Q3	$3K	Hold	200	–	–	﹤0.01%	333
2015 Q2	$3K	Buy	+200	New	+$3.57K	﹤0.01%	354
2014 Q2	–	Sell	-200	Closed	-$2K	–	163
2014 Q1	$2K	Hold	200	–	–	﹤0.01%	387
2013 Q4	$2K	Buy	+200	New	+$2.36K	﹤0.01%	369

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Kavar Capital Partners Group's BSX Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 200 shares — an estimated $9K sold.

Kavar Capital Partners Group first reported a position in BSX in Q4 2013 and held it in 8 quarters. The position peaked at $9K in Q2 2019. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

Kavar Capital Partners Group reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
Kavar Capital Partners Group sold 200 Boston Scientific shares in Q3 2019, an estimated $9K.
Kavar Capital Partners Group first reported a position in Boston Scientific in Q4 2013 and held it in 8 quarters.
Kavar Capital Partners Group's Boston Scientific position peaked at $9K in Q2 2019.
771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.